Washington SB 5391: Requiring the disclosure of drug production in improved residential real property sales.

Status: By resolution, reintroduced and retained in present status. (as of 2020-01-13)

State: Washington · Session: 2019-2020 · Bill: SB 5391

Subjects: REAL ESTATE AND REAL PROPERTY, DRUGS

Sponsors: Zeiger, Das, Hunt, Keiser, Mullet, Padden, Warnick

View Washington SB 5391 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.